FASEA confirms there’s no news on course approvals



The Financial Adviser Standards and Ethics Authority (FASEA) has been forced to clarify that it is yet to make any approvals for the provision of graduate diplomas and bridging courses, following some confusion yesterday as the Ethics Centre announced it was developing an ethics course for which it planned to gain accreditation.
FASEA yesterday advised that, while it had received 14 applications for accreditation by graduate diploma providers and 11 for bridging courses, it hadn’t approved any.
The Authority said that decisions regarding the applications wouldn’t be announced until mid-June, upon which the accredited courses would be available on its website.
“This would allow accredited providers sufficient time to commence offering accredited graduate diplomas and bridging courses in the second half of the 2019 calendar year,” it said.
This followed its previously-announced timeline for decisions, which was within eight weeks of receipt. The 25 applications from higher education providers above were all received before the cut-off date for approvals of 12 April.
The confusion regarding the Ethics Centre’s course arose yesterday after it said it was developing a FASEA-accredited offering, rather than that it had already received approval.
Recommended for you
For the 2025 financial year, all but one listed advice licensee has reported double-digit share price growth – but which licensee has seen the best performance and what activities have they enacted during the period?
Evidentia Group has confirmed its new executive leadership structure, having been formed from the merger between Evidentia and Lonsec Investment Solutions, to shape the future of managed accounts.
CC Capital, the last remaining player in the bid to acquire Insignia Financial, is still yet to finalise its offer, the firm has informed the market.
The top-performing investment platforms of 2025 have been revealed in the latest Money Management Advice Tech Review Survey by Agile Market Intelligence.